Home
Biosimilars: Understanding the Regulatory Processes and the Commercial Realities
21 September 2010
Biosimilars: Understanding the Regulatory Processes and the Commercial Realities

In association with Interpharm Consultancy

Overview of workshop

The aim of this workshop is to give participants a good overview of the whole topic of biosimilars while investigating in more depth those topics that merit it. Biosimilars have attracted a great deal of interest recently and are seen by some as the new generic frontier, since it is widely thought that lower levels of competition will lead to higher margins in an industry notorious for its generally low margins on commodity generics.

However, while lower regulatory barriers in less regulated markets have allowed a biosimilars market to take off, the higher regulatory barriers in Europe and issues of interchangeability have resulted in a limited number of product launches so far and slow progress for those that are already in the market. Across the Atlantic, the situation is changing with the long awaited legislation now in place to simplify biosimilars registration. How will the legislation actually work and is it what the generic industry was hoping for?

The workshop will look at all these issues and take a look into what the future may bring.
 

Want to register your place? Click here.
 

Upon completion of this workshop, attendees will gain:

  • A good overview of the Biosimilars picture across the world
  • Insight into the varying regulatory approaches prevailing in different regions
  • An understanding of the commercial situation as it is now and likely to develop in the future
  • Enough background to determine whether entering the biosimilars market is an appropriate strategy for their company
     

About the Master Class Leader

Peter Wittner, B.Sc., is an independent consultant specialising in the commercial aspects of generics with more than 30 years' pharmaceutical experience. Before starting his own business, Peter headed the European sales and marketing departments of the UK generics companies Evans Medical and H.N. Norton, which later became part of IVAX.

He later joined the Indian generic leader Ranbaxy as Managing Director to help set up its UK business and then returned to consultancy work. Interpharm advises new market entrants on generic strategies, assists in business development for generic companies based outside the EU that are trying to enter the market, works with companies that are seeking to enlarge their product portfolios and acts as an agent for a CRO providing biostudies to the generic industry. While mainly oriented to the commercial side with services such as market intelligence and pricing overviews for example, Interpharm also advise on IP and patent issues as well as the legal background to the pharmaceutical industry in Europe.
On the other side of the equation, Interpharm has also worked with originator companies that are looking at ways of defending their major brands from generic incursion.

In addition, Peter is a regular speaker at generic conferences and conducts training seminars on behalf of Management Forum. He has written a number of reports on generics industry topics including "Growth Strategies in Generics", "Generics Defense Strategies" and "US and European Prescription Generic Markets" as well as a series of reports for Decision Resources including one published in 2008 on Indian Generics. Peter is also a regular contributor to the GenericsWeb newsletter "INNsight".
 

About Interpharm Consultancy

Interpharm Consultancy specialises in offering support to the generic industry, particularly companies that are new to the field or based outside Europe. Peter Wittner set up the company in 1998 after leaving Ranbaxy with the intention of sharing his experience of the generic industry at both the national and international level.

Interpharm has cooperated with a number of generic companies to help them work out their strategy for expansion, but also with branded companies concerned about the potential impact of generics on certain of their brands that are nearing the end of the patent protection period.

Apart from giving assistance with market development and growth strategies, Interpharm works with companies looking to buy in new generic products to expand their portfolio and uses its connections with the major European generic groups to introduce overseas manufacturers to potential new business partners and markets.

Interpharm can also provide on-site training on strategic, legal and regulatory issues affecting the generics industry.

www.interpharm-consultancy.co.uk

Workshop agenda

clock

13:00

Registration & Coffee

clock

13:30

Welcome & Introductions

  • Peter Wittner's experience and qualifications
  • Purpose and scope of the workshop
  • clock

    13:40

    Overview - Biosimilars? Biogenerics? Follow-on Biologicals?

  • What are we actually talking about?
  • Summary of issues affecting Biosimilars
  • Regulatory
  • Legal / IP
  • Commercial
  • Interchangeability - what is the issue?
     
  • clock

    14:15

    The regulatory process and its pitfalls

  • Europe - a straight forward case
  • EMEA guidelines
  • Overview of successful and failed applications
  • The USA - How will the new legislation work out?
  • Comparison of proposals and final version
  • Probable shape of the new regulatory mechanism
  • Japan
  • How it compares to EU / US
  • Situation in other parts of the world
  • Less regulated markets
     
  • clock

    15:15

    Afternoon Coffee

    clock

    15:30

    Biosimilars - the commercial reality

  • What is the big attraction?
  • Biologicals market and prospects
  • Potential Biosimilars market
  • What has happened so far?
  • Europe and the USA
  • Asian markets and Latin America
  • Patents, IP and other issues
  • What are the patent issues?
  • Interchangeability - a potential roadblock
  • Differing national legislation
  • Where do Biosimilars go from here?
  • clock

    16:30

    Discussion Session

    clock

    17:00

    Close of Workshop

    Crowne Plaza - The City

    19 New Bridge Road
    London EC4V 6DB
    United Kingdom

    Crowne Plaza - The City

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.